T1 Diabetes | Dexcom Provider

the most accurate CGM is who we are, outcomes are what we're after^1-6

industry-leading accuracy in adults and pediatrics^7,8

Dexcom MARD vs Libre MARD

Dexcom G7 offers your T1D patients clinically proven results^1,4,9,10

USE OF A CGM HELPED IMPROVE OUTCOMES REGARDLESS OF WHETHER PATIENTS USED INSULIN PUMPS OR MDI^†,9,10

CGM use additionally demonstrated significant reduction of A1C compared to BGM¹¹

dexcom warrior

more time in range more time in range
Dexcom CGM was clinically proven to increase TIR^1,4,5

less frequent hypo- and hyperglycemic events
T1D users at high hypoglycemia risk experienced a 72% reduction in hypoglycemic events¹²

down arrow fewer long-term health complications
after 7 years, about 2x as many patients on BGM had newly diagnosed or progressive retinopathy compared to those on CGM¹¹

Dexcom CGM

connected with digital

health apps can help

increase TIR^13-16

the only CGM that enables

your patients to share their

numbers with up to 10

followers^‡

Dexcom CGM connects to a

suite of digital health app

options—simultaneously while

using an AID system

the only CGM that

connects to Garmin

smartwatches and direct

to Apple Watch^§,7

Dexcom has your patients covered with a growing ecosystem of 80+ partners that includes connected pumps, pens, and digital health apps^||,17

EXPLORE OUR PARTNERS

DEXCOM G7 IS THE ONLY CGM DESIGNED WITH URGENT LOW SOON AND DELAY FIRST HIGH ALERT⁷

helps prevent severe hypoglycemic events²⁰

Urgent Low Soon alert^¶ notifies patients of a severe low up to 20 minutes before it happens

helps prevent alert fatigue

Delay First alert notifies your patients when their numbers have been too high for too long–while also minimizing alert fatigue

get your patients

started for free today

PRESCRIBE & SAMPLE

more patients pay $0 for

Dexcom G7 compared to Libre^#,17

COVERAGE & AFFORDABILITY

BGM = blood glucose monitoring; CGM = continuous glucose monitoring; isCGM = intermittently scanned continuous glucose monitoring; T2D = type 2 diabetes; TAR = time above range; TBR = time below range.

*Comparing Dexcom CGM and BGM for patients with T2D on insulin. †Secondary outcome, not meeting power (P<0.05). Incretin and SGLT2 use was similar with CGM and BGM and likely contributed to weight loss outcomes at 12 months. ‡Results obtained from previous Dexcom device(s). §Cardiovascular risk refers to 10-year ASCVD risk. Visit https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/ to access the American College of Cardiology ASCVD Risk Estimator Plus. ||Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings. ¶Individual pricing may vary depending on commercial insurance coverage.

1 Lind N, et al. Diabetes Care. 2024;47(5):881-889. 2 Ehrhardt N, et al. Clin Diabetes. 2020;38(2):126-131. 3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 4 Martens T, et al. JAMA. 2021;325(22):2262-2272. 5 Grace TP, et al. Clin Diabetes. 2024;42(4):540-546. 6 Clark TL, et al. Diabetes Technol Ther. 2024;26(10):700-708. 7 Reed J, et al. Diabetes Obes Metab. 2024;26(7):2881-2889. 8 Dexcom G7 User Guide, 2024. 9 Dexcom, Data on File, 2024.

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Request a Visit from a Dexcom Representative

Request a G7 Sample

Request Stelo Education Materials

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information. A valid business address is required for a request to be fulfilled.

Do not include prefix (Mr., Mrs., Dr.)

As listed on Provider’s medical license (no MD, Jr., Sr.)

Please use the Provider’s NPI

Please provide Facility/Office address Only- We will not ship to home address

Is your patient on a connected pump device?

Yes

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense samples of the Dexcom G6 Continuous Glucose Monitoring System and/or Dexcom‘s next generation product, Dexcom G7 (the "Samples"). I represent that I am requesting the Samples for evaluation purposes and that I will not (i) sell, resell, barter, return for credit or seek reimbursement for the use of the Samples, or (ii) for professional services for dispensing or evaluating the Samples, I also agree to inform my patients that they should not submit claims for reimbursement to any third party for any Samples.

The Samples are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither devices nor receivers are included in the Samples. Accordingly, and in light of the applicable G6 or G7 Dexcom Instructions for Use, you should dispense Samples only to a patient who (or whose authorized caregiver), in the exercise of your clinical judgment, (i) has reliable access to a compatible smart device and/or automated insulin delivery system, and (ii) is capable of safely using the Samples with their smart device, without the need for a separate dedicated receiver.

Please note that Medicare will reimburse for sensors only if the beneficiary also uses a receiver covered by Medicare. Accordingly, it is appropriate to give Samples to Medicare patients only if they have (in the case of the G6 Samples) or would be eligible to obtain (in the case of the G7 Samples), a Medicare-covered receiver.

You agree that you will not provide the Samples to any patients that are beneficiaries under the Maine or Colorado state Medicaid programs. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Samples. I agree not to reuse any Samples. I acknowledge that Dexcom provides no warranties for the Samples other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Samples, and I agree to store and use these Samples in a manner consistent with the applicable Dexcom Instructions for Use. Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

LBL-1004145 Rev001

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense these Dexcom G6 Continuous Glucose Monitoring Systems and/or Dexcom‘s next generation product, Dexcom G7 (the "Dexcom Education Devices") which are provided in the quantities listed above.

The Dexcom Education Devices are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither smart devices nor receivers are included with the Dexcom Education Devices. I understand that these Dexcom Education Devices are being requested for me and other healthcare professionals ("HCPs") for evaluation purposes to learn more about the Dexcom Education Devices and experience the benefits of the Dexcom Education Devices through a product demonstration, and that each HCP will need a compatible smart device for the product demonstration.

I acknowledge that Dexcom provides no warranties for the Dexcom Education Devices other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use, and agree not to reuse any Dexcom Education Devices. I agree to receive, store, distribute, and/or use these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use and device labeling. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Dexcom Education Devices. I understand and agree to properly dispose of the Dexcom Education Devices immediately following the completion of the product demonstration. The Dexcom Education Devices are being provided at no cost, without any expectation of remuneration, HCPs have no obligations under the federal supply schedule contract for participating in the product demonstration, and Dexcom waives any rights under this contract or applicable law to pursue a claim for the costs associated with the Dexcom Education Devices.

Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.

industry-leading accuracy in adults and pediatrics7,8

Contact Us

industry-leading accuracy in adults and pediatrics^7,8